Non reciprocal cross-sensitization between cocaine and BTCP on locomotor activity in the rat

被引:5
作者
Martin-Fardon, R [1 ]
Ben-Shahar, O [1 ]
Weiss, F [1 ]
机构
[1] Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA
关键词
BTCP; cocaine; locomotor activity; rats; sensitization;
D O I
10.1016/S0091-3057(00)00262-8
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Measurement of locomotor sensitization was employed to characterize the effect of intermittent treatment with N-[1-(2-benzo[b] thiophenyl)cyclohexyl]piperidine (BTCP) and cocaine in the rat. Like cocaine, BTCP possesses high affinity for the dopamine transporter and inhibits dopamine reuptake. Although both drugs exhibit similar behavioral and neurochemical profiles with acute administration, there is tentative evidence to suggest that following chronic treatment BTCP does not induce neurochemical sensitization, and can attenuate cocaine-induced neurochemical sensitization in the striatum. Male Wistar rats were randomly divided into five groups after determining baseline locomotor activity. Three groups were treated with tither saline (saline/ saline), cocaine (20 mg/kg; cocaine/cocaine), or BTCP (10 mg/kg; BTCP/BTCP) for 10 days. The remaining two groups were treated with cocaine (20 mg/kg) or BTCP (10 mg/kg) for 3 days, followed by administration of BTCP (10 mg/kg; cocaine/ BTCP) or cocaine (20 mg/kg; BTCP/cocaine) for 7 days. Locomotor sensitization was observed in all groups. However, although cross-sensitization on the day of substitution (day 4) was found in the BTCP/cocaine group, cross-sensitization was not observed in the cocaine/BTCP group. These results suggest that although the locomotor-activating effects of BTCP and cocaine are similar, the two drugs do not act identically, and different neural mechanisms may underlie BTCP and cocaine-induced sensitization. (C) 2000 Elsevier Science Inc.
引用
收藏
页码:631 / 635
页数:5
相关论文
共 54 条
[1]   SUBCHRONIC COCAINE TREATMENT ENHANCES COCAINE-INDUCED DOPAMINE EFFLUX, STUDIED BY INVIVO INTRACEREBRAL DIALYSIS [J].
AKIMOTO, K ;
HAMAMURA, T ;
OTSUKI, S .
BRAIN RESEARCH, 1989, 490 (02) :339-344
[2]  
AKUNNE HC, 1994, J PHARMACOL EXP THER, V268, P1462
[3]   DIFFERENCES IN DOPAMINE CLEARANCE AND DIFFUSION IN RAT STRIATUM AND NUCLEUS-ACCUMBENS FOLLOWING SYSTEMIC COCAINE ADMINISTRATION [J].
CASS, WA ;
GERHARDT, GA ;
MAYFIELD, RD ;
CURELLA, P ;
ZAHNISER, NR .
JOURNAL OF NEUROCHEMISTRY, 1992, 59 (01) :259-266
[4]   REDUCTION IN DOPAMINE TRANSPORTER MESSENGER-RNA AFTER CESSATION OF REPEATED COCAINE ADMINISTRATION [J].
CERRUTI, C ;
PILOTTE, NS ;
UHL, G ;
KUHAR, MJ .
MOLECULAR BRAIN RESEARCH, 1994, 22 (1-4) :132-138
[5]   ROLE OF THE AROMATIC GROUP IN THE INHIBITION OF PHENCYCLIDINE BINDING AND DOPAMINE UPTAKE BY PCP ANALOGS [J].
CHAUDIEU, I ;
VIGNON, J ;
CHICHEPORTICHE, M ;
KAMENKA, JM ;
TROUILLER, G ;
CHICHEPORTICHE, R .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1989, 32 (03) :699-705
[6]   1-[1-(2-benzo[b]thiopheneyl)cyclohexyl]piperidine hydrochloride (BTCP) yields two active primary metabolites in vivo -: Identification and quantification of BTCP primary metabolites in mice plasma, urine, and brain and their affinity for the neuronal dopamine transporter [J].
Deleuze-Masquefa, C ;
Michaud-Dutreilh, M ;
Vignon, J ;
Kamenka, JM .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2000, 9 (04) :345-354
[7]  
DELFS JM, 1990, J NEUROSCI, V10, P303
[8]  
DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274
[9]  
Downs AW, 1932, J PHARMACOL EXP THER, V46, P199
[10]  
Downs AW, 1932, J PHARMACOL EXP THER, V46, P195